Alberta Investment Management Corp (AIMCo)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-182,793
| Closed | -$33.6M | – | 1104 |
|
|
2021
Q2 | $33.6M | Buy |
182,793
+75,709
| +71% | +$13.9M | 0.28% | 78 |
|
|
2021
Q1 | $16.4M | Buy |
107,084
+43,584
| +69% | +$6.66M | 0.15% | 149 |
|
|
2020
Q4 | $9.92M | Buy |
+63,500
| New | +$9.92M | 0.09% | 262 |
|
|
2020
Q3 | – | Sell |
-10,500
| Closed | -$1.18M | – | 1198 |
|
|
2020
Q2 | $1.18M | Sell |
10,500
-1,600
| -13% | -$180K | 0.01% | 610 |
|
|
2020
Q1 | $1.09M | Hold |
12,100
| – | – | 0.02% | 554 |
|
|
2019
Q4 | $1.31M | Sell |
12,100
-53,000
| -81% | -$5.73M | 0.01% | 600 |
|
|
2019
Q3 | $6.38M | Buy |
+65,100
| New | +$6.38M | 0.06% | 288 |
|
|
2018
Q3 | – | Sell |
-4,300
| Closed | -$534K | – | 925 |
|
|
2018
Q2 | $534K | Buy |
+4,300
| New | +$534K | ﹤0.01% | 697 |
|
|
2018
Q1 | – | Sell |
-4,200
| Closed | -$502K | – | 845 |
|
|
2017
Q4 | $502K | Buy |
+4,200
| New | +$502K | ﹤0.01% | 640 |
|
|
2017
Q2 | – | Sell |
-32,000
| Closed | -$3.88M | – | 871 |
|
|
2017
Q1 | $3.88M | Buy |
+32,000
| New | +$3.88M | 0.03% | 344 |
|
|
2016
Q4 | – | Sell |
-45,900
| Closed | -$5.63M | – | 833 |
|
|
2016
Q3 | $5.63M | Buy |
+45,900
| New | +$5.63M | 0.06% | 267 |
|
|
2016
Q2 | – | Sell |
-47,000
| Closed | -$6.54M | – | 703 |
|
|
2016
Q1 | $6.54M | Buy |
47,000
+25,700
| +121% | +$3.58M | 0.09% | 208 |
|
|
2015
Q4 | $4.06M | Buy |
21,300
+1,400
| +7% | +$267K | 0.05% | 372 |
|
|
2015
Q3 | $3.11M | Buy |
19,900
+5,554
| +39% | +$869K | 0.04% | 397 |
|
|
2015
Q2 | $2.59M | Buy |
+14,346
| New | +$2.59M | 0.03% | 422 |
|